Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized Human Rabies Vaccine (Serum-free Vero Cells) Batch Consistency and Safety Trial in Adults 18–45 Years
CTR20260543Phase 3Active
- Sponsor
- Bio-Therapeutic Biotech
- Start
- Feb 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of lyophilized human rabies vaccine in rabies, sponsored by Bio-Therapeutic Biotech. Started Feb 2026; status: active.
02
Drugs
lyophilized human rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20260543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260543.